Syneos Health, Inc. (SYNH) Tops Q2 EPS by 1c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Syneos (SYNH) PT Raised to $105 at Jefferies
August 10, 2021 8:29 AM EDTJefferies analyst David Windley raised the price target on Syneos (NASDAQ: SYNH) to $105.00 (from $102.00) while maintaining a Buy rating.
The analyst commented, "Bookings highlighted SYNH's 2Q, particularly Clinical with 1.45x b2b for 2Q and 1.37x TTM. Because SYNH's revenue and... More
